Bioequivalence Study of Terbinafine Hydrochloride Tablets, 250 mg of Dr. Reddy's Under Fed Conditions
NCT01286701
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
18
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
Terbinafine Hydrochloride Tablets, 250 mg
Sponsor
Dr. Reddy's Laboratories Limited